Analyst Price Targets — TBPH
| Date | Analyst | Firm | Target | Price @ Post | Source | Headline |
|---|---|---|---|---|---|---|
| December 3, 2025 11:16 am | — | Oppenheimer | $27.00 | $18.43 | TheFly | Theravance Biopharma initiated with an Outperform at Oppenheimer |
| November 26, 2025 12:14 pm | — | BTIG | $40.00 | $18.94 | TheFly | Theravance Biopharma price target raised to $40 from $25 at BTIG |
| November 13, 2024 2:39 pm | David Risinger | Leerink Partners | $10.00 | $7.66 | StreetInsider | Leerink Partners Reiterates Market Perform Rating on Theravance Biopharma (TBPH) |
| August 6, 2024 6:08 am | Douglas Tsao | H.C. Wainwright | $15.00 | $9.59 | TheFly | Theravance Biopharma price target lowered to $15 from $20 at H.C. Wainwright |
| April 12, 2024 6:36 am | Julian Harrison | BTIG | $21.00 | $8.93 | StreetInsider | BTIG Starts Theravance Biopharma (TBPH) at Buy |
| November 17, 2022 6:03 am | — | Leerink Partners | $14.00 | $11.22 | Benzinga | SVB Leerink Maintains Outperform on Theravance Biopharma, Raises Price Target to $14 |
Latest News for TBPH
CorMedix and Theravance take sharply different routes to small-cap biotech growth - one fueled by sales traction, the other by pipeline promise.
Hillsdale Investment Management Inc. acquired a new stake in Theravance Biopharma, Inc. (NASDAQ: TBPH) in the undefined quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor acquired 310,700 shares of the biopharmaceutical company's stock, valued at approximately $4,536,000. Hillsdale Investment Management
Theravance Biopharma (NASDAQ: TBPH - Get Free Report) and Amylyx Pharmaceuticals (NASDAQ: AMLX - Get Free Report) are both small-cap medical companies, but which is the superior business? We will compare the two businesses based on the strength of their valuation, earnings, dividends, risk, profitability, analyst recommendations and institutional ownership. Profitability This table compares Theravance Biopharma and
Investors need to pay close attention to TBPH stock based on the movements in the options market lately.
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
🧮 Earnings Move Analyzer
Insider Trading
Insider Trading
| Name | Role | Date | Type | Shares | Price | Form | Link |
|---|
Senate Trading
No Senate trades found for TBPH.
U.S. House Trading
House Trades Disclosures
| Name | Transaction Date | Type | Asset | Amount | Link |
|---|
Options Chain
Select an expiration to expand. Bid/Ask are shown first (before Mark) on both sides.